The median fold changes in peripheral Cldn1 and TGF-β in HCC patients were 1.93–3.6- and 1.78–2.95-fold higher, respectively, than those in the other groups (P < 0.0001/all). The gene discussed is CLDN1; the disease is hepatocellular carcinoma.